Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04074122
Other study ID # 70856
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date January 1, 2022

Study information

Verified date August 2019
Source Maastricht University Medical Center
Contact Rachel ter Bekke, MD, PhD
Phone +31433877095
Email rachel.ter.bekke@mumc.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

High-resolution, non-invasive electromechanical mapping in genotyped long-QT syndrome patients and healthy controls at baseline and during smart provocation.


Description:

Using simultaneous ECG-imaging, speckle-tracking analysis and tissue-phase mapping with MRI we will assess electromechanical dispersion at rest. Regional electromechanical elasticity will be investigated during adenosine and epinephrine, isoprenaline infusions and is postulated to increase sudden cardiac death risk prediction in the individual patient.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date January 1, 2022
Est. primary completion date January 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

LQTS group (Group 1):

- Diagnosis of LQTS according to the ESC guidelines.

- Genetic testing either already performed or consent to genetic testing (at least 5 major LQTS-related genes tested: KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2).

Control group (Group 2):

? Control subjects with structurally normal hearts.

Exclusion Criteria:

- Pregnancy, nursing or planning to become pregnant.

- Known allergy or strong reaction to skin electrodes or contrast agent.

- Inability to give informed consent.

- Presence of metal objects in or attached to the body.

- Dialysis.

- Cardiomyopathy.

- Second-degree heart block or higher degrees of block.

- Sick sinus syndrome.

- Asthma.

- Chronic obstructive pulmonary disease.

- Left-main coronary artery disease.

- Unstable coronary artery disease.

Study Design


Intervention

Diagnostic Test:
Adenosine and epinephrine, isoprenaline provocation
High-resolution electromechanical mapping at baseline and after provocative measures.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Maastricht University Medical Center University of Bern, University of Freiburg

References & Publications (6)

Haugaa KH, Amlie JP, Berge KE, Leren TP, Smiseth OA, Edvardsen T. Transmural differences in myocardial contraction in long-QT syndrome: mechanical consequences of ion channel dysfunction. Circulation. 2010 Oct 5;122(14):1355-63. doi: 10.1161/CIRCULATIONAH — View Citation

Haugaa KH, Edvardsen T, Leren TP, Gran JM, Smiseth OA, Amlie JP. Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome. Eur Heart J. 2009 Feb;30(3):330-7. doi: 10.109 — View Citation

Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol. 2000 Mar 1;35(3):778-86. — View Citation

ter Bekke RM, Haugaa KH, van den Wijngaard A, Bos JM, Ackerman MJ, Edvardsen T, Volders PG. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk. Eur Heart J. 2015 Jan 14;36(3):179-86. doi: 10.1093/eurhea — View Citation

ter Bekke RM, Volders PG. Arrhythmogenic mechano-electric heterogeneity in the long-QT syndrome. Prog Biophys Mol Biol. 2012 Oct-Nov;110(2-3):347-58. doi: 10.1016/j.pbiomolbio.2012.07.007. Epub 2012 Jul 24. Review. — View Citation

Viskin S, Rosso R, Rogowski O, Belhassen B, Levitas A, Wagshal A, Katz A, Fourey D, Zeltser D, Oliva A, Pollevick GD, Antzelevitch C, Rozovski U. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with lo — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Differences in regional electromechanical dispersion between LQTS patients and controls Electromechanical dispersion in milliseconds At day of investigation
Primary Differences in regional electromechanical dispersion between symptomatic and asymptomatic LQTS patients Electromechanical dispersion in milliseconds At day of investigation
Secondary Correlation of electromechanical dispersion between LQTS type 1, 2, and 3. Electromechanical dispersion in milliseconds At day of investigation
Secondary Relation between global electromechanical window vs regional electromechanical dispersion in LQTS Electromechanical dispersion in milliseconds At day of investigation
Secondary Correlation between mechanical dispersion using TPM-MRI and cine-MRI Time-to-diastolic peak in milliseconds At day of investigation
Secondary Correlation between mechanical dispersion using TPM-MRI and speckle-tracking echocardiography Time-to-peak in milliseconds At day of investigation
See also
  Status Clinical Trial Phase
Recruiting NCT03453645 - Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
Completed NCT05791032 - Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study N/A
Completed NCT05970120 - A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter N/A
Completed NCT04011631 - Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System. N/A
Recruiting NCT03536052 - Ablation at Virtual-hEart pRedicted Targets for VT N/A
Not yet recruiting NCT06063811 - Ventricular Tachycardia Ablation in LVAD Patients
Enrolling by invitation NCT02962076 - Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia Early Phase 1
Not yet recruiting NCT02784912 - Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation N/A
Completed NCT01791543 - Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia N/A
Terminated NCT02891863 - Low Energy Therapy to Convert Ventricular Tachycardias Phase 0
Terminated NCT01546207 - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia N/A
Completed NCT01294267 - Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation N/A
Terminated NCT00383799 - Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia Phase 4
Completed NCT04884100 - enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening N/A
Completed NCT04642963 - Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia N/A
Recruiting NCT05377216 - Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation Early Phase 1
Not yet recruiting NCT04990089 - VIVO European Observational Registry
Completed NCT04065893 - Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
Recruiting NCT03631303 - Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias
Recruiting NCT03611465 - Creation of a Pace-mapping Atlas on Healthy and Pathological Hearts N/A